Navigation Links
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Date:8/19/2007

SAN DIEGO, Aug. 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ANX-510, or CoFactor(R) injection, which is currently being investigated in a pivotal Phase 3 study, with 5-fluorouracil (5-FU) and bevacizumab for the initial treatment of metastatic colorectal cancer. CoFactor is a folate-based biomodulator drug designed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-FU.

"The FDA's fast track designation represents a significant step towards bringing CoFactor to market as rapidly as possible," stated Evan M. Levine, chief executive officer of ADVENTRX. "We look forward to working closely with the FDA to expedite the review and approval process for CoFactor."

The fast track programs of the Food and Drug Administration (FDA) are designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track status enables a sponsor to have more frequent and timely communication and meetings with the FDA regarding product development plans and may also result in eligibility for priority review of New Drug Applications. Fast track designation does not apply to a product alone but a combination of a product and specific indication.

ADVENTRX is currently conducting a 1,200-patient, Phase 3 clinical study of CoFactor for the tre
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
2. Adventrx Announces Positive Data From Multidrug Therapy With CoFactor
3. ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... YORK , September 22, 2014 ... Market Report on "Global Market Study on Ophthalmic Devices: ... by 2020," the global ophthalmic devices market was valued at USD ... at a CAGR of 6.5% from 2014 to 2020, ... in 2020. Browse the full Global Market Study ...
(Date:9/22/2014)...  AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... machines, announced today that they are starting production of ... unit is designed for placement inside optical shops and ... statistics, there are over 20,000 optical stores in ... world,s first automated kiosk dedicated to cleaning and sanitizing ...
(Date:9/22/2014)... 2014  Neuralstem, Inc. (NYSE MKT: CUR) announced that ... Emory University, presented long-term follow up data on the ... in the treatment of amyotrophic lateral sclerosis (ALS or ... at the Annual Symposium on ALS of the Foundation ... Friday, and was not open to the public, covered ...
Breaking Medicine Technology:Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
... Oncimmune ® LLC , maker of EarlyCDT™-Lung , a ... and early detection of lung cancer , today announced ... International Conference May 13 - 18 in Denver will collectively ...  Oncimmune,s EarlyCDT-Lung test uses a panel of tumor ...
... (Polaris) today announced that the Company will highlight clinical ... ADI-PEG 20, during a symposium held on Tuesday, May ... Taiwan. Details about Polaris, upcoming pivotal Phase ... (HCC) will be presented by the principal investigator, Ghassan ...
Cached Medicine Technology:Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 2Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 3Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 4Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 5Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 2Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 3
(Date:9/22/2014)... Jose, California (PRWEB) September 22, 2014 ... Respiratory care market occupies a significant presence in ... the most widespread healthcare problems globally. Key factors ... unhealthy lifestyle habits such as smoking; increasing levels ... COPD; and expanding base of aging population vulnerable ...
(Date:9/22/2014)... September 22, 2014 The report ... Spain) aesthetic lasers and energy devices market revenue ... Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) ... also provides company shares by revenue for the ... Scope,     Information on market size ...
(Date:9/22/2014)... 2014 The Spa Standard, announced today ... the start-up in developing content and courses for their ... company over 15 years of experience in massage therapy, ... management with companies including Orient Express Hotels and the ... of educator, Jenny gained extensive industry insight through planning, ...
(Date:9/22/2014)... of modern medical development is medical imaging which ... monitoring, disease detection and treatments. The devices and ... without the use of image processing, pattern recognition, ... are areas of active research development which are ... the areas. A partial list of the important ...
(Date:9/22/2014)... MA, September 22, 2014 The American Association ... guidelines for the prevention and treatment of perioperative ... thoracic surgical procedures. The guidelines are published in ... . , "These guidelines have the potential to ... of patients who undergo lung surgery in the ...
Breaking Medicine News(10 mins):Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 3Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 4Health News:The Spa Standard Appoints Vice-President of Content and Course Development 2Health News:Researchers uncover the frontiers of R&D in medical imaging 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 3Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 4
... Doheny HealthDay Reporter , FRIDAY, Aug. 5 (HealthDay ... physically active, a new study finds that performance often trumps ... gained from about six months of exercise proved more satisfying ... the research. This suggest that with advancing years, a shift ...
... In summer, more dishes like gazpacho a cold soup containing ... new study has revealed that ingredients, vitamin C content as ... mixture, meaning that it should be eaten immediately after preparation., ... vitamin loss? A new study has examined gazpacho, one of ...
... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
... , THURSDAY, Aug. 4 (HealthDay News) -- People living ... the "Stroke Belt" are known to have significantly higher rates ... research reveals these residents are also at greater risk for ... "In 2010, we examined death rates from sepsis across ...
... discovery by scientists at Duke University Medical Center and ... effective combination of drug therapy to treat the second ... scientists have been looking for the primary cancer genes ... two chromosomes that held the probable mutations, but not ...
... 4 (HealthDay News) -- A map of the genetic mutations ... appears to reveal the biological cause of the tumors, researchers ... in seven samples of tissue from oligodendroglioma tumors, and concentrated ... previously associated with those types of tumors. The genes ...
Cached Medicine News:Health News:With Age, Focus on Body Shifts From Appearance to Function 2Health News:With Age, Focus on Body Shifts From Appearance to Function 3Health News:Gazpacho ingredients lose vitamin C during preparation 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:U.S. 'Stroke Belt' May Also Be 'Sepsis Belt' 2Health News:Elusive gene mutations found for malignant brain tumor 2Health News:Scientists May Have Found Missing Link to Common Brain Cancer 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: